Bill Sponsor
Senate Bill 3635
116th Congress(2019-2020)
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Introduced
Introduced
Introduced in Senate on May 6, 2020
Overview
Text
Sponsor
Introduced
May 6, 2020
Latest Action
May 6, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3635
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Arkansas
Republican
Florida
Republican
Indiana
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Protecting Our Pharmaceutical Supply Chain from China Act of 2020

This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.

Text (1)
Actions (2)
05/06/2020
Read twice and referred to the Committee on Finance.
05/06/2020
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:42:44 PM